Methusalem Podcast

Methusalem Podcast with Niklas Anzinger

41 min · 23 de feb de 2026
portada del episodio Methusalem Podcast with Niklas Anzinger

Descripción

In this episode of the Methusalem Podcast, I discuss with Niklas Anzinger, founder and CEO of Infinita City, the story behind Próspera, a special economic zone on the island of Roatán, Honduras. Niklas shares his journey from public policy and the Berlin startup scene to building a jurisdiction designed to accelerate biotech and longevity innovation. We cover how Próspera operates as a startup city with its own regulatory framework, why Niklas believes FDA-style regulatory monopolies are the biggest bottleneck in longevity research rather than the science itself, and how Próspera's insurance-based regulatory model offers a market-driven alternative. We also discuss biotech companies already operating on-site. If you're a founder or researcher interested in launching a biotech company in this unique regulatory environment, check out the BioHub Startup Accelerator at luma.com/BioHub2026 [https://luma.com/BioHub2026]. For more information on Infinita City and everything happening at Prospera, visit the homepage at infinita.city [https://www.infinita.city/].

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y forma parte de la comunidad de Methusalem Podcast!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

5 episodios

episode Methusalem Podcast with Niklas Anzinger artwork

Methusalem Podcast with Niklas Anzinger

In this episode of the Methusalem Podcast, I discuss with Niklas Anzinger, founder and CEO of Infinita City, the story behind Próspera, a special economic zone on the island of Roatán, Honduras. Niklas shares his journey from public policy and the Berlin startup scene to building a jurisdiction designed to accelerate biotech and longevity innovation. We cover how Próspera operates as a startup city with its own regulatory framework, why Niklas believes FDA-style regulatory monopolies are the biggest bottleneck in longevity research rather than the science itself, and how Próspera's insurance-based regulatory model offers a market-driven alternative. We also discuss biotech companies already operating on-site. If you're a founder or researcher interested in launching a biotech company in this unique regulatory environment, check out the BioHub Startup Accelerator at luma.com/BioHub2026 [https://luma.com/BioHub2026]. For more information on Infinita City and everything happening at Prospera, visit the homepage at infinita.city [https://www.infinita.city/].

23 de feb de 202641 min